Back to Results
First PageMeta Content
Biology / Meningococcal disease / Pfizer / Sanofi Pasteur / Vaccination / NmVac4-A/C/Y/W-135 / Meningococcal vaccine / Vaccines / Prevention / Medicine


Addressing the Challenges of Serogroup B Meningococcal Disease Outbreaks on Campuses Monday, November 17, [removed]:00 PM ET
Add to Reading List

Open Document

File Size: 1,57 MB

Share Result on Facebook

Company

Merck & Co. Inc. / MedImmune / Pfizer Inc. / Novartis Vaccines and Diagnostics Inc. / Cubist / Merck & Co. / Inc. / Serogroup / Sanofi / Dynavax / Sigma-Tau Pharmaceuticals Inc. / Genentech / /

Country

United States / /

Event

FDA Phase / /

Facility

Research Texas Children’s Hospital / Microbiology Baylor College / /

IndustryTerm

healthcare professionals / prevention of infectious diseases / online evaluation / /

MedicalCondition

meningococcal disease / infectious diseases / /

MedicalTreatment

vaccination / /

Organization

Advisory Committee on Immunization Practices / Accreditation Council for Continuing Medical Education / Baylor College of Medicine / Center for Vaccine Awareness & Research Texas Children / Managing Meningococcal Disease Outbreaks / National Foundation for Infectious Diseases / FDA / Vaccine Awareness & Research Texas Children’s Hospital Houston / /

Person

Carol J. Baker / Susan J. Rehm / William Schaffner / Marla Dalton / J. Baker / Ellyn Terry / /

/

Position

advisor / Professor of Pediatrics / Executive Director / President / speaker / medical director / director / content reviewer / consultant / /

Product

US / Meningococcal B vaccine / /

URL

http /

SocialTag